Pierluigi di Mauro (Pierluigi Di Mauro)

Years Active: 2020-2023
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Emma Zattarin, Daniele Presti, Luigi Mariani, Caterina Sposetti, Rita Leporati, Alice Menichetti, Chiara Corti, Chiara Benvenuti, Giovanni Fucà, Riccardo Lobefaro, Francesca Ligorio, Leonardo Provenzano, Andrea Vingiani, Marta Del Vecchio, Gaia Griguolo, Marianna Sirico, Ottavia Bernocchi, Antonio Marra, Paola Zagami, Elisa Agostinetto, Flavia Jacobs, Pierluigi di Mauro, Andrea Esposito, Carlo Alberto Giorgi, Luca Lalli, Laura Boldrini, Pier Paolo Berton Giacchetti, Ambra Carnevale Schianca, Valentina Guarneri, Rebecca Pedersini, Agnese Losurdo, Alberto Zambelli, Daniele Generali, Carmen Criscitiello, Curigliano Giuseppe, Giancarlo Pruneri, Filippo de Braud, Maria Vittoria Dieci, Claudio Vernieri
Prognostic significance of HER2-low status in HR-positive/HER2-negative advanced breast cancer treated with CDK4/6 inhibitors. NPJ breast cancer 9 (1) (2023)
Paolo Bossi, Cristina Gurizzan, Luigi Lorini, Pierluigi di Mauro, Chiara Sardini, Marco Merlano
Not all hematopoietic growth factors are created equal: should we gain information for their use with immunotherapy? Journal for immunotherapy of cancer 9 (8) (2022)
Pierluigi di Mauro, Vittorio Ferrari
Bronchoesophageal Fistula. The New England journal of medicine 383 (25) (2020)

Pierluigi di Mauro.css-eqlu8i{font-size:small;padding-left:4px;} (Pierluigi Di Mauro)